SEC Filing Summary: Astro-Med, Inc. (8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Astro-Med, Inc. on April 3, 2013. The report addresses a specific corporate governance action taken by the Compensation Committee of the Board of Directors regarding executive compensation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references "consolidated Operating Income" solely as a benchmark for calculating bonus limitations but does not disclose the actual financial figures for the period.
Material Changes
The primary material change reported is an amendment to the Astro-Med, Inc. Management Bonus Plan for Group III (executive officers). The amendment clarifies the application of the 10% cap on combined annual bonuses relative to consolidated Operating Income:
- The 10% limitation applies strictly to bonuses based on achieving financial objectives.
- Bonuses based on achieving business objectives are explicitly excluded from this 10% cap.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or discussion of new risks or contingencies. The document is limited to the administrative clarification of the bonus plan structure.
Investor Verification Checklist
- Verify the full text of the amended Management Bonus Plan (Exhibit 10.1) to understand the specific definitions of "financial objectives" versus "business objectives."
- Confirm the impact of this amendment on potential executive compensation payouts in the current fiscal year.
- Review subsequent filings for the actual consolidated Operating Income figures to assess the financial baseline for the bonus cap.